Eli Lilly (LLY) is strengthening its presence in genetic medicine with a deal worth $261.7 million to acquire Adverum Biotechnologies (ADVM), a ...
M&A News: Eli Lilly’s (LLY) $262M Acquisition of Adverum Bolsters Gene Therapy Push
Eli Lilly (LLY) is strengthening its presence in genetic medicine with a deal worth $261.7 million to acquire Adverum Biotechnologies (ADVM), a ...